SCHEMBL178876

SCHEMBL178876

CCN(CC)c1ccc(/C=C/C=C(C#N)C#N)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 5/20 0.61
ALDH1A1 P00352 11/20 0.50
MEN1 O00255 10/20 0.50
KMT2A Q03164 10/20 0.50
MAPT P10636 9/20 0.50
MAPK1 P28482 6/20 0.50
L3MBTL1 Q9Y468 5/20 0.50
POLB P06746 3/20 0.50
TDP1 Q9NUW8 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
GAA P10253 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
HBB P68871 1/20 0.48
ALDH3A1 P30838 1/20 0.47
ALDH1A3 P47895 1/20 0.47
KDM4E B2RXH2 1/20 0.46
LMNA P02545 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178835 0.90 APP (0.55) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL178872 0.88 APP (0.52) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL123560 0.84 APP (0.61) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL178834 0.83 APP (0.47) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL10053864 0.82 APP (0.88) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL6226940 0.82 APP (0.88) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL10746356 0.82 APP (0.58) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL10746358 0.82 APP (0.58) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL9361374 0.81 MEN1 (0.58) APPALDH1A1MEN1KMT2AMAPT
SCHEMBL9361378 0.81 MEN1 (0.58) APPALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10254562-B2 Methods for tailoring the refractive index of lenses BATTELLE MEMORIAL INSTITUTE (US) 2019-04-09 US disclosed
US-10018853-B2 Methods of altering the refractive index of materials BATTELLE MEMORIAL INSTITUTE (US) 2018-07-10 US disclosed
US-9827088-B2 Methods of altering the refractive index of materials BATTELLE MEMORIAL INSTITUTE (US) 2017-11-28 US disclosed
US-9421090-B2 Adjustable intraocular lens BATTELLE MEDICAL INSTITUTE (US) 2016-08-23 US disclosed
US-20160228238-A1 METHODS OF ALTERING THE REFRACTIVE INDEX OF MATERIALS BATTELLE MEMORIAL INSTITUTE 2016-08-11 US disclosed
US-20160229132-A1 METHODS OF ALTERING OPTICAL POWER OF A LENS BATTELLE MEMORIAL INSTITUTE 2016-08-11 US disclosed
US-20160221283-A1 METHODS FOR TAILORING THE REFRACTIVE INDEX OF LENSES BATTELLE MEMORIAL INSTITUTE (US) 2016-08-04 US disclosed
US-20160221281-A1 LENS MODIFICATION METHODS BATTELLE MEMORIAL INSTITUTE 2016-08-04 US disclosed
US-20160195734-A1 METHODS OF ALTERING THE REFRACTIVE INDEX OF MATERIALS BATTELLE MEMORIAL INSTITUTE 2016-07-07 US disclosed
US-20160195735-A1 METHODS FOR TAILORING THE REFRACTIVE INDEX OF LENSES BATTELLE MEMORIAL INSTITUTE 2016-07-07 US disclosed
US-9232993-B2 Adjustable intraocular lens BATTELLE MEMORIAL INSTITUTE (US) 2016-01-12 US disclosed
WO-2015038620-A2 METHODS FOR TAILORING THE REFRACTIVE INDEX OF LENSES BATTELLE MEMORIAL INSTITUTE (US) 2015-03-19 WO disclosed
WO-2015038614-A1 METHODS OF ALTERING THE REFRACTIVE INDEX OF MATERIALS BATTELLE MEMORIAL INSTITUTE (US) 2015-03-19 WO disclosed
WO-2015038623-A1 LENS MODIFICATION METHODS BATTELLE MEMORIAL INSTITUTE (US) 2015-03-19 WO disclosed
WO-2015038611-A1 METHODS OF ALTERING OPTICAL POWER OF A LENS BATTELLE MEMORIAL INSTITUTE (US) 2015-03-19 WO disclosed
EP-2578185-A2 Adjustable intraocular lens BATTELLE MEMORIAL INSTITUTE (US) 2013-04-10 EP disclosed
US-20120268710-A1 ADJUSTABLE INTRAOCULAR LENS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2012-10-25 US disclosed
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2012-03-08 US disclosed
WO-2009124231-A1 ADJUSTABLE INTRAOCULAR LENS BATTELLE MEMORIAL INSTITUTE (US) 2009-10-08 WO disclosed
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use INCENP, CYBA, ADCY5 APP 2538/4885ALDH1A1 371/4885MEN1 4480/4885
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use INCENP, CYBA, PAICS APP 2995/4885ALDH1A1 378/4885MEN1 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.